Skip to content

Digital Mental Health Service for Non-Treatment Seeking Young Adults

Digital Mental Health Service for Non-Treatment Seeking Young Adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04948268
Enrollment
120
Registered
2021-07-01
Start date
2023-10-27
Completion date
2024-10-25
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Suicidal Ideation

Keywords

Text messaging, Depression, Anxiety, Telemedicine, Digital Mental Health, mobile health (mHealth), Mobile phone, Technology assisted, Smartphone, Cell phone, Coach

Brief summary

This is a feasibility trial of a personalized 8-week text messaging intervention aimed at young adults (ages 18-25) with depression and anxiety who are not interested in -- or experience barriers to -- receiving traditional face-to-face psychological treatments. The trial will consist of a pilot test of (1) an 8-week adaptive (personalized) messaging intervention relative to (2) a non-personalized digital mental health intervention, or (3) an active control which will send weekly psychoeducation information by way of Uniform Resource Locators (URLs). The adaptive intervention will uses machine learning to tailor Short Message Service (SMS) messages to an individual's needs and preferences, and URL links to provide access to psychoeducational content to contextualize messages, when the length of that content exceeds the limitations of messages. The primary goals of the project are to conduct a feasibility trial using a sequential multiple assignment randomized treatment (SMART) design, which will evaluate (a) the effectiveness of an adaptive, personalized messaging intervention in reducing engagement relative to a non-personalized version; and (b) whether human coaching results in greater symptom reduction and engagement, relative an unguided implementation.

Detailed description

The primary purpose of this trial is to test the feasibility of conducting a randomized controlled trial of digital mental health intervention (DMHI) for non-treatment seeking young adults with symptoms of depression or anxiety, comparing an 8-week adaptive (personalized) messaging intervention, an 8-week non-personalized digital mental health intervention, or an active control which will deliver psychoeducational content via clickable URLs. The adaptive intervention will be powered by reinforcement learning to deliver tailored SMS messages based on user profiles and the ways in which a user interacts with the intervention system, along with links to longer psychoeducational content. The non-personalized intervention arm will not personalize the messages, but will still be an active treatment. This study will examine the adaptive intervention's ability to engage users and effectiveness in decreasing psychological distress relative to a non-personalized intervention. Participants who become disengaged (5 continuous days of not clicking on content URL links, responding to messages, or message ratings) from the adaptive or static intervention arms at any point in the first two weeks of treatment will be randomized to receive low-intensity human coaching or continue without coaching for the remainder of the intervention period. Recruitment will take place via Mental Health America's (MHA) website. MHA is a large mental health advocacy organization that hosts online screeners and has large number of visitors the majority of whom meet clinical cutoffs for depressive or anxiety disorder symptoms. This study will enroll individuals who have completed a depression or anxiety disorder screener on MHA's website, and meet clinical cut-offs on the Patient Health Questionnaire - 9 (PHQ-9) or Generalized Anxiety Disorder - 7 (GAD-7). Initial randomization will be generated in permuted blocks of 5 using a computer program. To prevent allocation bias, randomization will be conducted by the biostatistician, who will not inform the study team of the treatment arms until the baseline assessment has been completed and the patient has been enrolled. Second randomization of disengaged participants will occur as disengagement is detected during the first two weeks. Half (50%) of disengaged individuals will be randomized to receive additional human coaching throughout the remainder of the study while remaining in either the adaptive or non-personalized treatment arms. The disengaged participants not randomized to receive additional human coaching will continue to receive either the non-personalized or adaptive automated treatment the participants were randomized to initially. Coaching will consist of providing users with support and accountability via positive reinforcement, goal and expectation setting, and monitoring. Coaching outreach will focus on adherence to the treatment but will not provide treatment advice. Coaches will provide a brief (15-minute phone call or equivalent depending on the medium) engagement session over the phone, SMS, or email, depending user preference. Thereafter, coaches will check in with participants via messaging, phone call, or email, twice per week and respond to patient texts. Participants will be assessed using self-report measures at baseline, weeks 4, 8, 12, and 16 weeks.

Interventions

Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages. Content and messages will be tailored using machine learning.

BEHAVIORALNon-personalized messaging intervention

Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages. Psychological content will center on a single psychological strategy each week. There will not be any tailoring of messaging and content based on group or individual level data.

BEHAVIORALCoaching

Human coaching to support intervention use and engagement via telephone calls, text or email

BEHAVIORALPsychoeducational links

SMS messages with URLs containing brief psychoeducational information.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study uses a sequential multiple assignment randomized trial (SMART) design. The first level of randomization is to one of the three treatment conditions: self-guided non-personalized intervention, self-guided adaptive intervention, or active control. The second level of randomization occurs during the first two weeks of intervention. Participants who meet criteria for disengagement from either the non-personalized or adaptive intervention are then randomized to receive coaching or continue as self-guided. This will provide the investigators with preliminary information on the need for and value of coaching. Participants will receive the assigned intervention from baseline to week 8, followed by an 8 week follow-up period

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

1. Ages 18 to 25 \*The age to provide consent in Nebraska is 19. Individuals recruited from the state of Nebraska must be 19 or older. 2. A positive screen on an MHA screen for depression (Patient Health Questionnaire - 9 \[PHQ-9\]) or anxiety (Generalized Anxiety Disorder - 7 \[GAD-7\]); 3. Resident of the United States. 4. Owns a smartphone

Exclusion criteria

1. Current treatment with psychotherapy or psychiatric medication management; 2. Seeking or plans to seek traditional mental health treatment (psychotherapy or psychiatric medication management) in next 8 weeks; 3. Serious mental illness for which intervention would be contraindicated (e.g., psychotic disorder, manic episode, etc.) 4. Severe suicidality (i.e., experiencing suicidal ideation with a plan and intent to act); 5. English insufficient to engage in design activities.

Design outcomes

Primary

MeasureTime frameDescription
Kessler Psychological Distress Scale16 weeks10-item self-report measure of transdiagnostic distress, used as outcome measure across diagnostic categories. Higher scores mean greater distress. Minimum score: 10; maximum score: 50
Engagement Length62 daysLast message/content rating or click on content URL link received from participant. This measure can include select individuals who exceed 56 days of interaction due to user's ability to temporarily pause receipt of messages, resulting in messages extending beyond 8 weeks (56 days).

Secondary

MeasureTime frameDescription
Patient Health Questionnaire-916 weeks10-item self-report measure assessing depression symptom severity. Higher scores mean greater symptom severity. Minimum score: 0; maximum score: 27
Generalized Anxiety Disorder-716 weeks8-item self-report measure assessing generalized anxiety disorder symptom severity Higher scores mean greater symptom severity. Minimum score: 0; maximum score: 21

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid C Mohr, PhD

Northwestern University

Participant flow

Recruitment details

Participants were recruited from the Mental Health America (MHA) screening website. Website visitors who completed a depression or anxiety screening form and obtained a score of 10 or higher on either screener were eligible to see an advertisement for our study that contained a link to an informational page and eligibility screening form. Those meeting eligibility criteria were given an option of providing informed consent.

Pre-assignment details

Prior to random assignment, participants who provided affirmative informed consent were required to have completed baseline assessments, confirm their ability to receive text messages as part of the intervention, and complete required payment forms.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
4 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
36 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
29 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Psychological Distress (Kessler 10/K10 Score)33.5 Score
STANDARD_DEVIATION 6.77
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
21 Participants
Sex/Gender, Customized
Participants Analyzed
Female
89 Participants
Sex/Gender, Customized
Participants Analyzed
Male
6 Participants
Sex/Gender, Customized
Participants Analyzed
Non-binary
2 Participants
Sex/Gender, Customized
Participants Analyzed
Self-describe
1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 340 / 300 / 60 / 100 / 40
other
Total, other adverse events
0 / 340 / 300 / 60 / 100 / 40
serious
Total, serious adverse events
0 / 340 / 300 / 60 / 100 / 40

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026